Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05584189 · ClinicalTrials.gov registry record · NA
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
A NA study, sponsored by MP Biomedicals.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT05584189 is a NA study that has completed, run by MP Biomedicals. The registered enrollment target is 99 participants.
The verdict
NCT05584189, a NA study, has completed, sponsored by MP Biomedicals.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
SARS-CoV-2 rapid antigen over the counter usability study.
Interventions
- DEVICE Rapid SARS-CoV-2 Antigen Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2021-10-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05584189
The ClinicalTrials.gov registry entry for NCT05584189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MP Biomedicals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rapid SARS-CoV-2 Antigen Test is the first listed.
NCT05584189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05584189 about?
NCT05584189 is a clinical study titled "COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability". SARS-CoV-2 rapid antigen over the counter usability study.
What is the current status of trial NCT05584189?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2021-10-07. Estimated completion is 2021-10-27.
What interventions are being tested in trial NCT05584189?
The interventions under investigation include: Rapid SARS-CoV-2 Antigen Test (DEVICE).
Who is sponsoring clinical trial NCT05584189?
This trial is sponsored by MP Biomedicals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.